LOGIN  |  REGISTER
C4 Therapeutics

Nutex Health Hospitals Gain Community Recognition and Take Home Seven Patient Satisfaction Awards in Q1

April 16, 2024 | Last Trade: US$30.28 1.49 -4.69

HOUSTON, April 16, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced Nutex hospitals have won seven awards and four recognitions in the first quarter of 2024, reflecting the staff's commitment to excellence.

Nutex Health hospitals have historically served as the safety net for the communities in which we serve. We believe that the main reason our hospitals are recognized for superior healthcare delivery is our organization's primary focus on patient care. Patients always come first, and our entire organization and its processes revolve around delivering the best patient care possible for the communities we serve.

Each award was voted on by their respective communities, demonstrating patient satisfaction and unparalleled service.

  • Phoenix ER won a spot on the Chandler Chamber of Commerce's "Top 100 Businesses of Chandler, Arizona" in January.
  • Albuquerque ER & Hospital East was awarded the "2023 Merit Award – Medical" in March from the NAIOP Commercial Real Estate Development Association.
  • Texarkana Emergency Center & Hospital won "Best Emergency Room/Hospital" in March for the Bowie County Citizens Tribute.
  • Texarkana Emergency Center & Hospital won "Best Emergency Room/Hospital" in the March issue of ALT Magazine.
  • Texarkana Emergency Center & Hospital won "Best Emergency Care" in the March issue of Four States Living Magazine.
  • The Colony ER Hospital was announced "Best Urgent/Emergency Care Finalist" in March for the Star Local Readers' Choice 2023 Best of The Colony.
  • Wylie ER won "Best ER" in March for the 2024 Best of Annual Readers' Choice Awards.

Other notable recognitions include:

  • The Colony ER Hospital's Chief Nursing Officer, Russell Kaiser, was named a "Visionary Leader Finalist in the Richard Harder Visionary Leader Award" for Nursing Management Magazine's February issue.
  • Albuquerque ER & Hospital's Chief Executive Officer, Dr. Sanjay K. Kholwadwala, was voted "Top Docs of ABQ 2024" in the Emergency Medicine category for Albuquerque Magazine's March edition.
  • Tulsa ER & Hospital's Facility Administrator, Kim Reid, was featured as a "Woman of Tulsa" in the March issue of She is Tulsa Magazine.
  • Oklahoma ER & Hospital's RN, Keith Curran, was recognized as a "2024 Healthcare Hero" by the Journal Record in March. This marks the hospital's eighth Healthcare Hero recognition in four years.

"We are extremely proud of the recognition our partner hospitals are receiving.  These accolades validate our mission of providing concierge-level care for all our patients," said Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health. "The highly-skilled teams at our facilities are passionate about healthcare and it shows in their exemplary work."

The Nutex management model ensures that our hospitals can thrive in their communities, which is echoed by thousands of positive reviews as well as numerous nominations and awards each year.

About Nutex Health Inc.

Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.

The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 21 facilities in 9 states.

The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Our cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to deliver greater quality care more efficiently.

Forward-Looking Statements

Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "expects to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including final rules implemented under the No Surprises Act and related regulatory guidance, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2023 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB